AbbVie · 2 weeks ago
2026 Regulatory Affairs U.S. Advertising and Promotion Intern (PharmD)
Mettawa, IL
Internship
Onsite
Intern
$59K/yr - $100K/yr
Start in 2026 SummerAbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The intern will join the Regulatory Affairs U.S. Advertising and Promotion Standards Team, learning about FDA regulations and assisting in various departmental initiatives.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Learning the FDA Regulations on Drug Advertising & Promotion
Understanding the detailed USAP activities
Creating reports, including metrics, department highlights and communications
Attending meetings
Creating presentation materials for USAP All Staff Meetings (ASM)
Creating templates to standardize communication
Reviewing current processes and assessing areas for improvement
Review of materials created by commercial marketing and/or R&D
Qualification
Required
Currently enrolled in university, pursuing a PharmD with interest in U.S. Advertising and Promotion
Must be enrolled in university for at least one semester following the internship
Expected graduation date between December 2026 – July 2027
Strong Communicator (verbal & written)
Strong work ethic
Highly motivated and Inquisitive
Preferred
Science or Communication background
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Founded in 2013
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-09
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase